Given investment horizon of 30 days, Salix Pharmaceuticals Ltd. is expected to generate 2.93 times more return on investment than American. However, Salix is 2.93 times more volatile than American Funds Blue Chip Inc & Gr HLS IB. It trades about 0.07 of its potential returns per unit of risk. American Funds Blue Chip Inc & Gr HLS IB is currently generating about -0.35 per unit of risk. If you would invest 5,055 in Salix Pharmaceuticals Ltd. on April 26, 2012 and sell it today you would earn a total of 32.00 from holding Salix Pharmaceuticals Ltd. or generate 0.63% return on investment over 30 days.
Diversification
Average diversification
Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and American Funds Blue Chip Inc & in the same portfolio (assuming nothing else is changed)
97% of all equities and portfolios perform better than Salix Pharmaceuticals Ltd.. Compared with the overall equity markets, risk-adjusted returns on investments in Salix Pharmaceuticals Ltd. are ranked lower than 3 (%) of all global equities and portfolios over the last 30 days.
Over the last 30 days American Funds Blue Chip Inc & Gr HLS IB has generated negative risk-adjusted returns adding no value to investors with long positions.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
